Ophiobolin-O Reverses Adriamycin Resistance via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells

Multidrug-resistance is a major obstacle facing cancer chemotherapy. This paper demonstrates that novel compound Ophiobolin-O reverses MCF-7/ADR resistance to adriamycin (ADM). The IC(50) of ADM treated MCF-7 cells was 2.02 ± 0.05 µM and 74.00 ± 0.18 µM treated MCF-7/ADR cells, about 37-fold, compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wenxia, Lv, Cuiting, Zhu, Tonghan, Yang, Xue, Wei, Shanjian, Sun, Jieyin, Hong, Kui, Zhu, Weiming, Huang, Caiguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853746/
https://www.ncbi.nlm.nih.gov/pubmed/24240979
http://dx.doi.org/10.3390/md11114570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853746/
https://www.ncbi.nlm.nih.gov/pubmed/24240979
http://dx.doi.org/10.3390/md11114570

Ejemplares similares